The cost of Tymlos (abaloparatide) varies depending on insurance coverage, pharmacy, and geographic location. A typical retail price for Tymlos can be several thousand dollars for a month's supply.
How much does Tymlos cost without insurance?
Without insurance, a single 3 mL vial of Tymlos, intended for 30 days of treatment, can cost approximately $7,000 to $8,000 or more [1]. This price reflects the out-of-pocket expense at a retail pharmacy.
Does insurance cover Tymlos?
Insurance coverage for Tymlos can differ significantly. Many insurance plans offer some level of coverage, but patients may still be responsible for co-pays, deductibles, or co-insurance. Patients are advised to check with their specific insurance provider for details on coverage and any associated costs [1].
Are there patient assistance programs for Tymlos?
Yes, there are patient assistance programs available for Tymlos. Radius Pharmaceuticals, the manufacturer, offers programs that may help reduce out-of-pocket costs for eligible commercially insured patients [1]. These programs can sometimes lower the monthly cost to a set amount, such as $5 per prescription, for eligible individuals. Eligibility often depends on insurance status and income.
What is the difference between Tymlos and other osteoporosis medications?
Tymlos is a parathyroid hormone analog that works by stimulating bone formation. It is prescribed for postmenopausal women with osteoporosis at high risk for fracture. Other osteoporosis medications, such as bisphosphonates (e.g., alendronate, risedronate), SERMs (e.g., raloxifene), and other anabolic agents (e.g., teriparatide, which is the active ingredient in Forteo), have different mechanisms of action, administration methods, and risk profiles [2]. Tymlos has a boxed warning regarding osteosarcoma [3].
When does the patent for Tymlos expire?
Drug patent information, including expiry dates, is complex and can involve multiple patents. Information regarding specific patent expiry dates for Tymlos can be found through resources that track pharmaceutical patents [4].
What are the side effects of Tymlos?
Common side effects of Tymlos include nausea, headache, fatigue, dizziness, increased heart rate, and abdominal pain. A significant warning associated with Tymlos is an increased risk of osteosarcoma, a type of bone cancer, based on studies in rats. This medication should not be used by patients with a history of bone tumors or certain bone diseases, or those with Paget's disease of bone [3].
How is Tymlos administered?
Tymlos is administered as a subcutaneous injection, typically once daily for 24 months. It is usually injected into the thigh, abdomen, or upper arm [3].
Sources:
1. https://www.drugpatentwatch.com/blog/tymlos-cost-and-insurance-coverage
2. https://www.drugpatentwatch.com/blog/tymlos-vs-other-osteoporosis-medications-comparison
3. https://www.drugpatentwatch.com/blog/tymlos-abaloparatide-dosage-and-administration-guide
4. https://www.drugpatentwatch.com/drug/abaloparatide